Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-04
2011-01-04
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S147000, C544S278000, C544S284000, C544S317000, C544S350000, C546S112000
Reexamination Certificate
active
07863270
ABSTRACT:
The invention relates to cyclic hydrazone compounds and compositions including the cyclic hydrazone compounds according to formula (I):The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.
REFERENCES:
patent: 6384032 (2002-05-01), Ono et al.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 and 365.
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker (Modern Pharmaceutics) Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Demko Zachary
Ng Howard P.
Sun Lijun
Edwards Angell Palmer & & Dodge LLP
Hsi Jeffrey D.
McDowell Brian
Russett Mark D.
Synta Pharmaceuticals Corp.
LandOfFree
IL-12 modulatory compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-12 modulatory compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-12 modulatory compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740219